Atria Investments’s Genelux GNLX Stock Holding History

Atria Investments’s Portfolio GNLX Stock Details GNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,735	Closed	-$31.7K	–	2023
2025 Q1	$31.7K	Buy	+11,735	New	+$44K	﹤0.01%	1887

Other funds holding GNLX

WDC

Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $5.64B AUM

PWM

Provident Wealth Management Brentwood, Tennessee $331M AUM 15.75% 1-Year Est. Return

Atria Investments's GNLX Position: Q2 2025 in Review

Atria Investments sold out of Genelux (GNLX) in Q2 2025, closing a stake of 11,735 shares — an estimated $31.7K sold.

Atria Investments first reported a position in GNLX in Q1 2025 and held it in 1 quarter. The position peaked at $31.7K in Q1 2025. 61 funds tracked by Wall St. Rank hold GNLX as of Q2 2025.

Atria Investments reported no remaining Genelux position as of Q2 2025 after selling out during the quarter.
Atria Investments sold 11,735 Genelux shares in Q2 2025, an estimated $31.7K.
Atria Investments first reported a position in Genelux in Q1 2025 and held it in 1 quarter.
Atria Investments's Genelux position peaked at $31.7K in Q1 2025.
61 funds tracked by Wall St. Rank held Genelux as of Q2 2025.

Based on Atria Investments's 13F filing for Q2 2025, filed 4 Aug 2025.